127 related articles for article (PubMed ID: 38689205)
1.
Vaishnav J; Ampapathi RS
Biomol NMR Assign; 2024 Jun; 18(1):105-109. PubMed ID: 38689205
[TBL] [Abstract][Full Text] [Related]
2. M. tuberculosis class II apurinic/ apyrimidinic-endonuclease/3'-5' exonuclease (XthA) engages with NAD+-dependent DNA ligase A (LigA) to counter futile cleavage and ligation cycles in base excision repair.
Khanam T; Afsar M; Shukla A; Alam F; Kumar S; Soyar H; Dolma K; Pasupuleti M; Srivastava KK; Ampapathi RS; Ramachandran R
Nucleic Acids Res; 2020 May; 48(8):4325-4343. PubMed ID: 32232338
[TBL] [Abstract][Full Text] [Related]
3. Analysis of ligation and DNA binding by Escherichia coli DNA ligase (LigA).
Wilkinson A; Smith A; Bullard D; Lavesa-Curto M; Sayer H; Bonner A; Hemmings A; Bowater R
Biochim Biophys Acta; 2005 May; 1749(1):113-22. PubMed ID: 15848142
[TBL] [Abstract][Full Text] [Related]
4. NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.
Srivastava SK; Dube D; Kukshal V; Jha AK; Hajela K; Ramachandran R
Proteins; 2007 Oct; 69(1):97-111. PubMed ID: 17557328
[TBL] [Abstract][Full Text] [Related]
5. Structure-guided mutational analysis of the OB, HhH, and BRCT domains of Escherichia coli DNA ligase.
Wang LK; Nair PA; Shuman S
J Biol Chem; 2008 Aug; 283(34):23343-52. PubMed ID: 18515356
[TBL] [Abstract][Full Text] [Related]
6. Structure/function studies of the NAD
Fernandes A; Williamson A; Matias PM; Moe E
Extremophiles; 2023 Sep; 27(3):26. PubMed ID: 37712998
[TBL] [Abstract][Full Text] [Related]
7. Structure-guided Mutational Analysis of the Nucleotidyltransferase Domain of Escherichia coli DNA Ligase (LigA).
Wang LK; Zhu H; Shuman S
J Biol Chem; 2009 Mar; 284(13):8486-94. PubMed ID: 19150981
[TBL] [Abstract][Full Text] [Related]
8. Structure based identification of first-in-class fragment inhibitors that target the NMN pocket of M. tuberculosis NAD
Shukla A; Afsar M; Kumar N; Kumar S; Ramachandran R
J Struct Biol; 2021 Mar; 213(1):107655. PubMed ID: 33197566
[TBL] [Abstract][Full Text] [Related]
9. Effects of deletion and site-directed mutations on ligation steps of NAD+-dependent DNA ligase: a biochemical analysis of BRCA1 C-terminal domain.
Feng H; Parker JM; Lu J; Cao W
Biochemistry; 2004 Oct; 43(39):12648-59. PubMed ID: 15449954
[TBL] [Abstract][Full Text] [Related]
10. Mycobacterium tuberculosis NAD+-dependent DNA ligase is selectively inhibited by glycosylamines compared with human DNA ligase I.
Srivastava SK; Dube D; Tewari N; Dwivedi N; Tripathi RP; Ramachandran R
Nucleic Acids Res; 2005; 33(22):7090-101. PubMed ID: 16361267
[TBL] [Abstract][Full Text] [Related]
11. BRCT domain interactions in the heterodimeric DNA repair protein XRCC1-DNA ligase III.
Dulic A; Bates PA; Zhang X; Martin SR; Freemont PS; Lindahl T; Barnes DE
Biochemistry; 2001 May; 40(20):5906-13. PubMed ID: 11352725
[TBL] [Abstract][Full Text] [Related]
12. Structure guided understanding of NAD+ recognition in bacterial DNA ligases.
Lahiri SD; Gu RF; Gao N; Karantzeni I; Walkup GK; Mills SD
ACS Chem Biol; 2012 Mar; 7(3):571-80. PubMed ID: 22230472
[TBL] [Abstract][Full Text] [Related]
13. Role of a BRCT domain in the interaction of DNA ligase III-alpha with the DNA repair protein XRCC1.
Taylor RM; Wickstead B; Cronin S; Caldecott KW
Curr Biol; 1998 Jul; 8(15):877-80. PubMed ID: 9705932
[TBL] [Abstract][Full Text] [Related]
14. Solution structure and backbone dynamics of the human DNA ligase IIIalpha BRCT domain.
Krishnan VV; Thornton KH; Thelen MP; Cosman M
Biochemistry; 2001 Nov; 40(44):13158-66. PubMed ID: 11683624
[TBL] [Abstract][Full Text] [Related]
15. Characterization of mimivirus NAD+-dependent DNA ligase.
Benarroch D; Shuman S
Virology; 2006 Sep; 353(1):133-43. PubMed ID: 16844179
[TBL] [Abstract][Full Text] [Related]
16. NMR study of the structure and dynamics of the BRCT domain from the kinetochore protein KKT4.
Ludzia P; Hayashi H; Robinson T; Akiyoshi B; Redfield C
Biomol NMR Assign; 2024 Jun; 18(1):15-25. PubMed ID: 38453826
[TBL] [Abstract][Full Text] [Related]
17.
Roth BM; Varney KM; Yang H; Weber DJ; Tomkinson AE
Biomol NMR Assign; 2019 Oct; 13(2):305-308. PubMed ID: 31093909
[TBL] [Abstract][Full Text] [Related]
18. NMR mapping of PCNA interaction with translesion synthesis DNA polymerase Rev1 mediated by Rev1-BRCT domain.
Pustovalova Y; Maciejewski MW; Korzhnev DM
J Mol Biol; 2013 Sep; 425(17):3091-105. PubMed ID: 23747975
[TBL] [Abstract][Full Text] [Related]
19. Expression, purification, and biophysical characterization of the BRCT domain of human DNA ligase IIIalpha.
Thornton KH; Krishnan VV; West MG; Popham J; Ramirez M; Thelen MP; Cosman M
Protein Expr Purif; 2001 Apr; 21(3):401-11. PubMed ID: 11281714
[TBL] [Abstract][Full Text] [Related]
20. Phosphopeptide binding specificities of BRCA1 COOH-terminal (BRCT) domains.
Rodriguez M; Yu X; Chen J; Songyang Z
J Biol Chem; 2003 Dec; 278(52):52914-8. PubMed ID: 14578343
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
